TrueBlue, Inc. (TBI) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 5 Buy, 4 Hold, 1 Sell.
The consensus price target is $5.75 (low: $5.50, high: $6.00), representing an upside of 52.9% from the current price $3.76.
Analysts estimate Earnings Per Share (EPS) of $-0.60 and revenue of $1.57B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-4.17 vs est $-0.60 (missed -596.4%). 2025: actual $-1.61 vs est $-0.51 (missed -215.7%). Analyst accuracy: 23%.
TBI Stock — 12-Month Price Forecast
$5.75
▲ +52.93% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for TrueBlue, Inc., the average price target is $5.75, with a high forecast of $6.00, and a low forecast of $5.50.
The average price target represents a +52.93% change from the last price of $3.76.
Highest Price Target
$6.00
Average Price Target
$5.75
Lowest Price Target
$5.50
TBI Analyst Ratings
Buy
Based on 10 analysts giving stock ratings to TrueBlue, Inc. in the past 3 months
EPS Estimates — TBI
23%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$4.17
vs Est –$0.60
▼ 85.6% off
2025
Actual –$1.61
vs Est –$0.51
▼ 68.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — TBI
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.567B
vs Est $1.566B
▲ 0.1% off
2025
Actual $1.616B
vs Est $1.611B
▲ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
